Publish in this journal
Journal Information
Vol. 68. Issue 2.
Pages 164 (February 2015)
Letter to the Editor
DOI: 10.1016/j.rec.2014.09.013
Full text access
DIOCLES: Some Caveats and New Questions. Response
DIOCLES: algunos matices y nuevas preguntas. Respuesta
Visits
...
Jos?? A. Barrab??sa,b,
Corresponding author
jabarrabes@vhebron.net

Corresponding author:
, Alfredo Bardaj??a,c
a Principal investigators DIOCLES study
b Servicio de Cardiolog??a, Hospital Universitario Vall d’Hebron, VHIR, Universidad Aut??noma de Barcelona, Barcelona, Spain
c Servicio de Cardiolog??a, Hospital Universitario de Tarragona Joan XXIII, IIISPV, Universidad Rovira i Virgili, Tarragona, Spain
Related content
Rev Esp Cardiol. 2015;68:16310.1016/j.rec.2014.08.012
Fernando Rosell-Ortiz, Francisco Mellado-Vergel, Javier Garc??a del ??guila
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
To the Editor,

On behalf of the Scientific Committee and researchers of the DIOCLES registry,1 we wish to thank Rosell-Ortiz et al for their letter and their interest in our study. The results are certainly promising in that they show a decrease in the in-hospital and 6-month mortality rates among patients with acute coronary syndrome (ACS) with respect to that recorded in the MASCARA study, the most recent large registry carried out in Spain,2 and are in accordance with the progressive reduction in mortality due to ST-segment elevation acute myocardial infarction (STEMI) observed over the past 20 years. Undoubtedly, a number of factors have influenced this reduction, and the development of out-of-hospital emergency services is probably not the least important of them. Closely related to the latter aspect is the progressive incorporation of protocol-based networks for the management of patients with STEMI, in which prehospital care plays a major role.4,5 We agree with the authors of the letter in that the overall mortality occurring during the acute phase of STEMI is higher than the 6.6% recorded in our study,1 as this value does not take into account prehospital mortality, both to ensure coherence for comparison with previous registries2,3 and because it is very difficult to reliably estimate its incidence.

We did not examine the possible differences in mortality in the overall group of ACS patients or specifically in those who also had STEMI in terms of the level of care provided by hospitals or the Spanish autonomous community, aspects of unquestionable interest.6 We will attempt to analyze the data from the DIOCLES registry in this respect, but the relatively small size of the population, especially in the subgroup with STEMI, will probably make it impossible to draw firm conclusions. In this subgroup, the overall management strategy applied is almost certainly more relevant than the technological level of the treatment hospital. Extensive evidence indicates that the development of efficient regional networks to care for patients with STEMI, and that include both primary percutaneous coronary intervention and a pharmacoinvasive strategy when this intervention cannot be performed promptly, improves the percentage of reperfused patients and decreases infarction-related mortality. It was not our objective (nor is the sample size large enough) to compare the mortality rate of the patients initially treated with thrombolysis with that of those whose initial treatment was primary percutaneous coronary intervention. In any case, the results of the DIOCLES registry show that, in Spain, there is margin for improvement in the application of both reperfusion strategies.1 As is logical, care provided by an out-of-hospital emergency service was associated with a more frequent use of prehospital thrombolysis (48%), especially if the treatment was administered in a fully-equipped ambulance (56%). However, even in this setting, a significant number of patients underwent thrombolysis in the hospital.

The DIOCLES data coincide with those of previous studies2 in that the patients with unclassified ACS constitute the subgroup at highest risk, and we consider the attempt to identify the determinants of this greater risk, especially the modifiable factors, to be highly relevant. We appreciate the proposal of Rosell-Ortiz et al to carry out an in-depth analysis of the data in this respect.

References
[1]
J.A. Barrabés, A. Bardají, J. Jiménez-Candil, F. del Nogal Sáez, V. Bodí, N. Basterra, et al.
Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES.
Rev Esp Cardiol, (2014),
[2]
I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cuñat, E. Civeira, et al.
Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado): resultados globales.
Rev Esp Cardiol., 61 (2008), pp. 803-816
[3]
F. Arós, M. Heras, J. Vila, H. Sanz, I. Ferreira-González, G. Permanyer-Miralda, et al.
Reducción de la mortalidad precoz y a 6 meses en pacientes con IAM en el periodo 1995-2005. Datos de los registros PRIAMHO I, II y MASCARA.
Rev Esp Cardiol., 64 (2011), pp. 972-980
[4]
J.A. Gómez-Hospital, P.D. Dallaglio, J.C. Sánchez-Salado, A. Ariza, S. Homs, V. Lorente, et al.
Impacto en tiempos de actuación y perfil de los pacientes tratados con angioplastia primaria en el área metropolitana sur de Barcelona al implantar el programa Código Infarto.
Rev Esp Cardiol., 65 (2012), pp. 911-918
[5]
A. Íñiguez, V.A. Jiménez, J.A. Baz, M.V. Barreiros.
Resultados tras 6 años de funcionamiento de la red asistencial de reperfusión coronaria de pacientes con infarto agudo de miocardio en la Comunidad de Galicia-Área Sur (PROGALIAM Sur).
Rev Esp Cardiol., 66 (2013), pp. 506-507
[6]
V. Bertomeu, A. Cequier, J.L. Bernal, F. Alfonso, M.P. Anguita, J. Muñiz, et al.
Mortalidad intrahospitalaria por infarto agudo de miocardio: relevancia del tipo de hospital y la atención dispensada. Estudio RECALCAR.
Rev Esp Cardiol., 66 (2013), pp. 935-942
Copyright © 2014. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.